These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32248988)

  • 1. Dilated Cerebral Arteriopathy in Classical Pompe Disease: A Novel Finding.
    Viamonte M; Tuna I; Rees J
    Pediatr Neurol; 2020 Jul; 108():117-120. PubMed ID: 32248988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease.
    Laforêt P; Petiot P; Nicolino M; Orlikowski D; Caillaud C; Pellegrini N; Froissart R; Petitjean T; Maire I; Chabriat H; Hadrane L; Annane D; Eymard B
    Neurology; 2008 May; 70(22):2063-6. PubMed ID: 18505979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive Arteriopathy in Late-Onset Pompe Disease: Case Report and Review of the Literature.
    Malhotra K; Carrington DC; Liebeskind DS
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e172-e175. PubMed ID: 28647415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease.
    Sacconi S; Bocquet JD; Chanalet S; Tanant V; Salviati L; Desnuelle C
    J Neurol; 2010 Oct; 257(10):1730-3. PubMed ID: 20559845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.
    Hensel O; Schneider I; Wieprecht M; Kraya T; Zierz S
    Orphanet J Rare Dis; 2018 Apr; 13(1):57. PubMed ID: 29653542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Adult-onset Pompe Disease with Cerebral Stroke and Left Ventricular Hypertrophy.
    Hossain MA; Miyajima T; Akiyama K; Eto Y
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3046-3052. PubMed ID: 30093193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy.
    Bhui R; Spector AR
    Neuromuscul Disord; 2020 Apr; 30(4):329-330. PubMed ID: 32173248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial vasculopathy: an important organ damage in young adult patients with late-onset Pompe disease.
    Zhao Y; Yu X; Li D; He J; Li Y; Zhang B; Zhang N; Wang Q; Yan C
    Orphanet J Rare Dis; 2024 Jul; 19(1):267. PubMed ID: 39010129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.
    Case LE; Bjartmar C; Morgan C; Casey R; Charrow J; Clancy JP; Dasouki M; DeArmey S; Nedd K; Nevins M; Peters H; Phillips D; Spigelman Z; Tifft C; Kishnani PS
    Neuromuscul Disord; 2015 Apr; 25(4):321-32. PubMed ID: 25617983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Development in Infantile-Onset Pompe Disease Under Very Early Enzyme Replacement Therapy.
    Lai CJ; Hsu TR; Yang CF; Chen SJ; Chuang YC; Niu DM
    J Child Neurol; 2016 Dec; 31(14):1617-1621. PubMed ID: 27655474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
    van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
    Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation.
    But WM; Lee SH; Chan AO; Lau GT
    Hong Kong Med J; 2009 Dec; 15(6):474-7. PubMed ID: 19966354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy.
    Forsha D; Li JS; Smith PB; van der Ploeg AT; Kishnani P; Pasquali SK;
    Genet Med; 2011 Jul; 13(7):625-31. PubMed ID: 21543987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histologic ocular findings in pompe disease.
    Yanovitch TL; Banugaria SG; Proia AD; Kishnani PS
    J Pediatr Ophthalmol Strabismus; 2010; 47(1):34-40. PubMed ID: 20128552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered.
    El-Gharbawy AH; Bhat G; Murillo JE; Thurberg BL; Kampmann C; Mengel KE; Kishnani PS
    Mol Genet Metab; 2011 Aug; 103(4):362-6. PubMed ID: 21605996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe distal muscle involvement and mild sensory neuropathy in a boy with infantile onset Pompe disease treated with enzyme replacement therapy for 6 years.
    Schänzer A; Görlach J; Claudi K; Hahn A
    Neuromuscul Disord; 2019 Jun; 29(6):477-482. PubMed ID: 31101460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset Pompe disease with left-sided bronchomalacia.
    Yang CF; Niu DM; Jeng MJ; Lee YS; Taso PC; Soong WJ
    Respir Care; 2015 Feb; 60(2):e26-9. PubMed ID: 25316892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.
    Pichiecchio A; Sacco S; De Filippi P; Caverzasi E; Ravaglia S; Bastianello S; Danesino C
    J Neurol; 2017 Oct; 264(10):2110-2118. PubMed ID: 28856460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of a short cardiac PR interval in a 12-year-old girl with late-onset Pompe disease following enzyme replacement therapy.
    Fernández C; Legido A; Jethva R; Marks HG
    Genet Med; 2012 Aug; 14(8):757-8. PubMed ID: 22863876
    [No Abstract]   [Full Text] [Related]  

  • 20. Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients.
    Bernstein DL; Bialer MG; Mehta L; Desnick RJ
    Mol Genet Metab; 2010; 101(2-3):130-3. PubMed ID: 20638881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.